Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
Lancet Reg Health Eur
.
2023 Oct 11:34:100753.
doi: 10.1016/j.lanepe.2023.100753.
eCollection 2023 Nov.
Authors
Daniele De Luca
1
2
,
Manuel Sanchez-Luna
3
,
Karl Schettler
4
,
Louis Bont
5
6
,
Eugenio Baraldi
6
7
Affiliations
1
Division of Paediatrics and Neonatal Critical Care, "Antoine Béclère" Medical Centre, Paris Saclay University Hospitals, APHP, Paris, France.
2
Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris Saclay University, Paris, France.
3
Division of Neonatology, University Hospital Gregorio Marañon Madrid, Complutense University, Spain.
4
Division of Paediatric and Neonatal Intensive Care, Children's Hospital St. Marien GmbH, Landshut, Germany.
5
Department of Paediatrics, University Medical Centre Utrecht, the Netherlands.
6
Respiratory Syncytial Virus Network (RESVINET) Foundation, Zeist, the Netherlands.
7
Neonatal Intensive Care Unit, Department of Woman's and Child's Health, University Hospital of Padova, Padua, Italy.
PMID:
37927432
PMCID:
PMC10624979
DOI:
10.1016/j.lanepe.2023.100753
No abstract available